Latest Industry Insights

In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.

In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.

This article overviews the science behind the potential use of RRx-001as a “radiation buster” with anti-inflammatory and anti-free radical properties to prevent or reduce both GI-ARS and H-ARS.

We speak with Dr. Niall Martin, CEO of Artios Pharma, to learn more about the development of drugs to target the DNA damage response pathway in cancer.

We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.

In this interview, we speak to Vikram Devgan at NanoString Technologies to learn more about how added context from spatial biology techniques can provide more detailed insights during tissue analysis.

In this interview, we learn more about the support available for entrepreneurs looking to take their ideas from the bench to viable business.

In this opinion piece, Daniel Elgort takes a look at how bioinformatics has already shaped the cancer care landscape and how its role will continue to grow over time.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

In this interview with Anthony Schmitt PhD, senior vice president of science at Arima Genomics, we discover some of the advantages and applications of 3D genomics for fields such as cancer research and drug discovery.